Atlas Trials

Cardio Protective Effect of SGL2I in Hemodialysis Patients and Its Impact on Patient Quality of Life

Clinical trial NCT06759077 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06759077
Sponsor
Al-Azhar University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Kidney Diseases
Start date
2024-12-28
Primary completion
2024-12-28
Enrollment
126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.